Cluster Headache clinical trials
The registry lists 123 studies for Cluster Headache across more than 10 countries. 26 are recruiting or about to start. 101 of them are mainly about Cluster Headache (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.
Get an email when these change. Save the Cluster Headache studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Autonomic Technologies, Inc. (6) · Danish Headache Center (6) · Leiden University Medical Center (5) · Norwegian University of Science and Technology (5) · The University of Texas Health Science Center, Houston (5) · Assistance Publique Hopitaux De Marseille (4) · University Hospital, Ghent (3) · Teva Branded Pharmaceutical Products R&D, Inc. (3)
What is being tested here
Drugs under test in Cluster Headache studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Botulinum toxin type A | 1 | 1 | 3 |
| Lysergic Acid Diethylamide | 1 | 0 | 2 |
| Methylprednisolone | 1 | 1 | 2 |
| Capsaicin | 1 | 0 | 1 |
| Zavegepant | 1 | 0 | 1 |
| JZP258 | 1 | 0 | 1 |
| Magnesium Sulfate | 1 | 0 | 1 |
| Acetaminophen | 1 | 0 | 1 |
| Bupivacaine | 1 | 0 | 1 |
| Galcanezumab | 0 | 3 | 3 |
Drug classes tested here Serotonin receptor agonists 1 open · Psychedelics 1 open · CGRP receptor antagonists 1 open · Corticosteroids 1 open
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 7
- Nov 2026Effectiveness of Transcranial Direct Current in Patients With Persistent COVID-19 With Headaches and Chronic Pain. · Fundación Universidad Católica de Valencia San Vicente Mártir
- Dec 2026Yogabased Movements for Primary Headaches (Migraine and/or Cluster Headache) - YOURHEAD - a Pilot Study · Karolinska Institutet
- Feb 2027Efficacy of Light Therapy in Treatment of Chronic Cluster Headache · Assistance Publique Hopitaux De Marseille
- Apr 2027LSD to Improve Cluster Headache Impact Trial · Radboud University Medical Center
- May 2027Response to Combined Trigeminal and Occipital Nerve Stimulation for the Preventive Treatment in Chronic Cluster Headache · Salvia BioElectronics
- Oct 2027A First-in-human Study to Assess the Initial Safety, Tolerability, and Effectiveness of the ONSS Bilateral Occipital Nerve Field Stimulation System for the Prophylactic Treatment of Chronic Cluster Headache in Difficult-to-treat Subjects. · Man and Science, SA
- Oct 2027Lysergic Acid Diethylamide (LSD) as Treatment for Cluster Headache · University Hospital, Basel, Switzerland
Who these studies take
Of the 18 Cluster Headache studies recruiting now, 7 (39%) set no upper age limit and 6 (33%) stop at 75 or younger. 4 (22%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 4 (22%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 2 (11%) | 2 (11%) |
| 18 | 16 (89%) | 16 (89%) |
| 30 | 17 (94%) | 17 (94%) |
| 40 | 17 (94%) | 17 (94%) |
| 50 | 17 (94%) | 17 (94%) |
| 65 | 17 (94%) | 17 (94%) |
| 75 | 13 (72%) | 13 (72%) |
| 85 | 10 (56%) | 10 (56%) |
Across all 123 studies, recruiting or not: 59% stop at 75 or younger and 37% at 65; 9% take children; 0% are for women only and 1% for men only; 15% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Cluster Headache studies take
Of 26 interventional studies with no phase under Cluster Headache, half reached primary completion within 19 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Interventional, no phase | 19 mo10–25 · 26 studies | — | — |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
What changed recently
From the registry's own updates since Oct 11, 2026.
Started recruiting1
Studies
Recruiting first, then most recently updated. Showing 50 of 123. Browse all 123 → or search them.
- Effectiveness of Transcranial Direct Current in Patients With Persistent COVID-19 With Headaches and Chronic Pain.RecruitingNCT05780450Not applicable1 country
- Zavegepant Intranasal Spray for the Acute Treatment of Episodic Cluster HeadacheNot yet recruitingNCT07714369Phase 21 country
- Yogabased Movements for Primary Headaches (Migraine and/or Cluster Headache) - YOURHEADRecruitingNCT07348783Not applicable1 country
- Italian Trigeminal Autonomic Cephalalgias Assessment StudyRecruitingNCT078127401 country
- A Pivotal Clinical Study to Evaluate the MySalvia System for the Treatment of Resistant MigraineRecruitingNCT07719608Not applicable1 country
- Efficacy, Safety and Tolerability of Low Sodium Oxybate for Nocturnal Cluster Headache AttacksNot yet recruitingNCT06950281Phase 2
- High- vs Standard-Dose Intravenous Magnesium for Acute HeadacheRecruitingNCT07779486Not applicable1 country
- Response to Combined Trigeminal and Occipital Nerve Stimulation for the Preventive Treatment in Chronic Cluster HeadacheRecruitingNCT07113470Not applicable1 country
- Clinical Trial of Endoscopically Guided Injection of Exparel (Bupivacaine) for the Treatment of Craniofacial PainRecruitingNCT04930887Phase 21 country
- Pain Biomarker StudyEnrolling by invitationNCT03511846Phase 11 country
- The Will Erwin Headache Research Center - Cluster Headache StudyRecruitingNCT029103231 country
- Repeated GON Injections in CCHRecruitingNCT05324748Phase 31 country
- nVNS for the Prevention and Treatment of Primary HeadacheRecruitingNCT06277063Not applicable1 country
- China Headache and Vertigo Registry StudyRecruitingNCT049399221 country
- LSD to Improve Cluster Headache Impact TrialRecruitingNCT05477459Phase 21 country
- Pulsed Radiofrequency Combined With Platelet-Rich Plasma Applied to the Sphenopalatine Ganglion in Treating Episodic Cluster HeadacheNot yet recruitingNCT068822781 country
- Efficacy of Light Therapy in Treatment of Chronic Cluster HeadacheRecruitingNCT06540651Not applicable1 country
- SPG Pulsed Radiofrequency for Chronic Cluster HeadacheRecruitingNCT06787677Not applicable1 country
- Botulinum Toxin Type A Blockade of the Sphenopalatine Ganglion in Treatment-refractory Chronic Cluster HeadacheRecruitingNCT03944876Phase 35 countries
- Quest to Analyze One Thousand Humans MeditatingEnrolling by invitationNCT065833951 country
- Role of Specific microRNAs in Cluster HeadacheRecruitingNCT065033281 country
- Resting State Functional Connectivity in Cluster HeadacheRecruitingNCT062067721 country
- A Close Examination of Patient Experiences in Cluster Headache Clinical ResearchNot yet recruitingNCT059782581 country
- Incidence of Intravascular (IV) Injection During Trigeminal Nerve BlocksRecruitingNCT044673981 country
- Detection of Local Field Potentials in the Ventral Tegmental Area of the Midbrain in Chronic Cluster Headache PatientsNot yet recruitingNCT058570981 country
- Civamide Nasal Solution for Cluster HeadacheNot yet recruitingNCT01341548Phase 3
- A First-in-human Study to Assess the Initial Safety, Tolerability, and Effectiveness of the ONSS Bilateral Occipital Nerve Field Stimulation System for the Prophylactic Treatment of Chronic Cluster Headache in Difficult-to-treat Subjects.Active, not recruitingNCT07677137Not applicable1 country
- Lysergic Acid Diethylamide (LSD) as Treatment for Cluster HeadacheActive, not recruitingNCT03781128Phase 21 country
- Yogabased Movements for Primary Headaches (Migraine and/or Cluster Headache) - YOURHEAD - a Pilot StudyActive, not recruitingNCT07292090Not applicable1 country
- Personalised Process-based Psychological Interventions for Paediatric HeadachesCompletedNCT07418723Not applicable1 country
- Cerebral Metabolism in Patients With Refractory Chronic Cluster Headache Treated by Occipital Nerve StimulationCompletedNCT02081482Not applicable1 country
- Ketamine + Magnesium for Chronic Cluster Headache (KETALGIA)CompletedNCT04814381Phase 41 country
- Osteopathic Manual Therapy (OMT) and Brain Structure and Function in Primary Headache Patients: A Pilot StudyCompletedNCT06841627Not applicable1 country
- REsponse to Combined SONS and ONS in Chronic Cluster headachEActive, not recruitingNCT05868044Not applicable1 country
- Nurse Intervention TrialTerminatedNCT06200480Not applicable1 country
- Sphenopalatine Ganglion Pulsed Radiofrequency Treatment OutcomesCompletedNCT07370142Not applicable1 country
- Cluster Headache Treatment SurveyCompletedNCT060118111 country
- Cluster Headache Treatment With RimegepantCompletedNCT05264714Phase 21 country
- Atrioventricular Block and Cluster Headache (SEVA)Active, not recruitingNCT04406259Phase 41 country
- Refractory Chronic Cluster Headache: Exploring the Potential of Repetitive Transcranial Magnetic StimulationCompletedNCT06917144Not applicable1 country
- A Research Study to Examine Cutaneous Allodynia and Cluster HeadacheCompletedNCT003298361 country
- Hydration in Children and Adolescents With Primary HeadachesCompletedNCT06816849Not applicable1 country
- High Dose Vitamin D Plus Multivitamin in the Prevention of Cluster HeadacheTerminatedNCT04570475Not applicable1 country
- Treatment of Chronic Cluster Headache with TENS and ONSCompletedNCT05023460Not applicable1 country
- Eptinezumab in Participants With Episodic Cluster HeadacheCompletedNCT04688775Phase 319 countries
- A 1-year Trial to Inform About Long-term Exposure to Eptinezumab in Participants With Chronic Cluster Headache (cCH)CompletedNCT05064397Phase 39 countries
- Bilateral Occipital Nerve Field Stimulation for the Treatment of dtCCHSuspendedNCT06124534Not applicable1 country
- An Open Internet-based Survey and Natural Language Processing Project Analysing Written Monologues by Headache PatientsCompletedNCT051538761 country
- Risk Taking and Decision-making in Cluster Headache PatientsCompletedNCT064108721 country
- GON-injection for a Sooner and Better Treatment of Cluster HeadacheCompletedNCT04014634Phase 41 country